Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

3.80%

8.2¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-174

First 174 Last

Share
Profile

Follow
itsagas

13,721 Posts.

1461

21/08/21

18:34

Post #: 55469507
Share

Originally posted by imperatore: ↑

I would appreciate if anyone would have an explanation/idea and or comment:
By now it is apparently very clear all the management’s efforts in bringing forward the trial of ATL1102 is getting the approval from EMA in order to start trial in some (possibly more then one) locations in Europe which it is undoubtedly a good news but why the production of ATL1102 including the process of making it into an injectable drug has been granted to an American company located in California? This would add extra costs as they will have to forward (airfreight I believe) to European locations. It is hard to believe there was not any European company that could provide the same service in fact if I am not wrong when ATL1102 was eventually to be used for MS the production was given if I am not mistaking to a company located in Austria.
Could be a good strategy because it may mean they are very very confident to get the go ahead from FDA
even this latest set back. Any comments are welcomed.

Expand

Imp: Fiasco with Atl1103 for Acromegaly ..re manufacture of drug…

Also good idea to use manufacturer in US ..$$ which will service Europe and US..

watch the sp move closer to mid Sept 21

ANP Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
Upvote

1 Great analysis

Reply

Top Stories

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 1 more message in this thread...

First 174 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change 0.003(3.80%)		Mkt cap ! $81.90M

Open	High	Low	Value	Volume
8.0¢	8.3¢	7.9¢	$315.4K	3.911M

Buyers (Bids)

No.	Vol.	Price($)
4	403845	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.2¢	243491	3

View Market Depth

No.	Vol.	Price($)
4	403845	0.080
7	419824	0.079
7	678354	0.078
8	1027327	0.077
5	359571	0.076

Price($)	Vol.	No.
0.082	243491	3
0.083	116165	3
0.084	133014	3
0.085	187500	2
0.086	250000	1

Last trade - 12.41pm 08/11/2024 (20 minute delay)

PER (ASX) Chart